GBE1 and adult polyglucosan body disease: A preclinical study by our group explores the efficacy and mechanism of action of the polyglucosan-reducing compound 144DG11 (GHF 201) in GBE knockin (Gbeys/ys) mouse model and patient skin fibroblast of adult polyglucosan body disease (APBD).